Skip to main content

Fusarium moniliforme

NDC 22840-1674 · Greer Laboratories, Inc.

Generic nameFusarium moniliforme
Dosage formSOLUTION
RouteINTRADERMAL, PERCUTANEOUS, SUBCUTANEOUS
Active ingredient(s)GIBBERELLA FUJIKUROI
Strength.001 g/mL
Pharmacologic classAllergens [CS], Cell-mediated Immunity [PE], Fungal Proteins [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Fungal Allergenic Extract [EPC]
Marketing categoryBLA

Packages

22840-1674-1 — 5 mL in 1 VIAL, MULTI-DOSE (22840-1674-1)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

22840-1670 — Fusarium moniliforme, 22840-1671 — Fusarium moniliforme, 22840-1672 — Fusarium moniliforme, 22840-1673 — Fusarium moniliforme, 22840-5618 — Fusarium moniliforme, 22840-9607 — Aureobasidium pullulans, Curvularia spicifera, Gibberella fujikuroi, Mucor plumbeus and Rhizopus stolonifer, 22840-9608 — Aureobasidium pullulans, Curvularia spicifera, Gibberella fujikuroi, Mucor plumbeus and Rhizopus stolonifer, 22840-9609 — Aureobasidium pullulans, Curvularia spicifera, Gibberella fujikuroi, Mucor plumbeus and Rhizopus stolonifer, 22840-9610 — Aureobasidium pullulans, Curvularia spicifera, Gibberella fujikuroi, Mucor plumbeus and Rhizopus stolonifer, 22840-9612 — Aureobasidium pullulans, Curvularia spicifera, Gibberella fujikuroi, Mucor plumbeus and Rhizopus stolonifer, 22840-9613 — Aureobasidium pullulans, Curvularia spicifera, Gibberella fujikuroi, Mucor plumbeus and Rhizopus stolonifer, 22840-9636 — Gibberella fujikuroi and Fusarium solani, 22840-9637 — Gibberella fujikuroi and Fusarium solani, 22840-9638 — Gibberella fujikuroi and Fusarium solani, 22840-9639 — Gibberella fujikuroi and Fusarium solani, 22840-9641 — Gibberella fujikuroi and Fusarium solani

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels